Precision Biosciences Says USPTO to Reexamine Additional Cellectis Patents

The two patents deal with DNA vectors that can be used in gene mapping and site-directed gene insertion, and are related to a different pair of patents already under reexamination at the USPTO.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.